ITM Power Lands £86.5m for Chronos Factory, Yet Share Technicals Flash Caution Amid Analyst Split

ITM Power secures £86.5M government and equity funding for Chronos electrolyser line, but shares drop 1.95% as investors pivot to production milestones and mixed analyst outlooks.

The formal confirmation of a £46.5 million government grant for ITM Power’s next-generation electrolyser line should have been a clear catalyst. Instead, shares in the Sheffield-based company ended the week in the red, closing at €1.35 on Friday – a daily drop of 1.95% and a weekly decline of 8.51%. The market’s muted reaction underscores how thoroughly the funding had already been baked into the stock, leaving investors to focus on what comes next: execution.

The grant, awarded by the Department for Energy Security and Net Zero, is paired with a £40 million equity injection from Great British Energy, together earmarked for the Chronos manufacturing project at ITM’s existing Sheffield site. The facility will leverage processes already deployed on the Trident line, a strategy management says reduces execution risk while creating a scalable, high-throughput platform. CEO Dennis Schulz called the formal sign-off a milestone, positioning the company as a “natural partner” for UK hydrogen projects. Shares initially jumped 9.2% in London on the announcement day, but the gains eroded steadily as the session wore on.

That fade tells only part of the story. Berenberg, one of the more bullish voices on the stock, used the confirmed financing to lift its price target to 200 pence, sending a pointed signal in a sector that has lately struggled for momentum. Yet the broader analyst community remains sharply divided. Of the eleven analysts covering the stock, eight rate it a buy, three a hold, and one a sell – but their twelve-month price targets span an enormous range, from 55 pence to 310 pence. That chasm reflects deep uncertainty over whether ITM can convert its growing order book and government backing into sustainable profitability.

Technical indicators reinforce a picture of consolidation after violent swings. The shares stand 21.20% below their 50-day moving average of €1.72, but 26.31% above the 200-day average of €1.07. The 100-day average sits at €1.33, practically on top of the current price. The 14-day RSI of 42.0 signals neutral territory, neither oversold nor overbought, while the annualised 30-day volatility of 106.37% underscores the headline-driven nature of recent moves.

Zooming out, the stock’s trajectory has been anything but linear. The 52-week low of €0.65, struck in early February, has been followed by a run to a year-to-date high of €2.58 at the end of May – a gain that has since been nearly halved by the pullback. From that high, the current price represents a 47.44% decline, while from the low the advance still stands at 109.10%. On a year-to-date basis, shares are up 86.77%, and over the past twelve months they have added 36.73%.

With the £86.5m funding package now locked in, attention shifts squarely to the factory floor. Investors want to see the Chronos line move from financial commitments to tangible production capacity. The next scheduled test of sentiment will be the company’s annual report, which will offer a clearer view of progress on its shift towards recurring revenue models. Until then, the gap between analyst conviction and market price suggests the stock will remain a battleground between those who see a funded, gigawatt-scale future and those waiting for proof that the metal is being cut.